| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5510187 | Clinical Biochemistry | 2017 | 20 Pages |
Abstract
The study gives further evidence that antibodies against monomeric C-reactive protein may be considered an indicator of renal involvement in patients with SLE. Assessment of anti-mCRP supports monitoring of disease activity and can be used in evaluating the treatment effectiveness.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Katarzyna Jakuszko, Magdalena Krajewska, Katarzyna KoÅcielska-Kasprzak, Marta Myszka, Agata Sebastian, Katarzyna Gniewek, Piotr Wiland, Marian Klinger,